In this study, the authors develop a potent bispecific antibody targeting two epitopes within the SARS-CoV-2 receptor binding domain and showing robust prophylactic and therapeutic efficacy against XBB.1 infection in mice.
All Keywords
【저자키워드】 SARS-CoV-2, Infectious diseases, structural biology, Antiviral agents,
【저자키워드】 SARS-CoV-2, Infectious diseases, structural biology, Antiviral agents,